Learn More
Medchemexpress LLC ICL-CCIC-0019 1mg | 936498-64-5 | 572.46 g·mol⁻¹ | C26H44Br2N4 | 1 MG

Supplier: Medchemexpress LLC HY1158401MG
ICL-CCIC-0019 is a small-molecule inhibitor of choline kinase α (CHKα). It reduces cellular phosphocholine levels and has been reported to induce G1 cell-cycle arrest, endoplasmic reticulum stress, and apoptosis in cancer cell lines. The compound is supplied as a solid research reagent intended for biochemical and cellular studies of choline metabolism.
- Small-molecule CHKα inhibitor for biochemical and cellular studies.
- Reduces cellular phosphocholine and alters choline metabolism.
- Induces G1 cell-cycle arrest, endoplasmic reticulum stress, and apoptosis in cancer cell models.
- Supplied as a powder with high reported purity suitable for research use.
- Store sealed at -20 °C, away from moisture and light.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.